Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Ariel Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities for 2026."
For the quarter ended December 31, 2025, Ariel Fund gained +3.22%, performing in line with the Russell 2500 Value and Russell 2000 Value indices. Top contributors to performance included Sphere Entertainment (SPHR), Core Laboratories (CLB), and Madison Square Garden Entertainment (MSGE). Major detractors included Adtalem Global Education (ATGE), Mohawk Industries (MHK), and Gentex Corporation (GNTX). During the quarter, the fund added dental manufacturer Dentsply Sirona (XRAY) to the portfolio and made zero exits. Heading into 2026, management remains cautious due to macroeconomic headwinds and heavy market concentration, reinforcing its focus on high-conviction value investing.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Growth Outlook
Market outlook remains moderate conviction: Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Risk Appetite
Risk appetite posture is moderate conviction: Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Forward Guidance
Forward guidance signal: Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Language Signal
Tone analysis indicates above average conviction language: Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Perceived Risk
Perceived risk level is evaluated as above average conviction. Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
Time Horizon
Investment time horizon reflects a high conviction orientation. Ariel Fund returned +3.22% in Q4 2025, matching benchmarks, as the team initiated a new position in Dentsply Sirona and maintained a cautious, selective outlook on broader equities...
